A detailed history of Indie Asset Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Indie Asset Partners, LLC holds 2,099 shares of ABBV stock, worth $377,820. This represents 0.32% of its overall portfolio holdings.

Number of Shares
2,099
Previous 2,145 2.14%
Holding current value
$377,820
Previous $367,000 12.81%
% of portfolio
0.32%
Previous 0.3%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$163.84 - $199.33 $7,536 - $9,169
-46 Reduced 2.14%
2,099 $414,000
Q2 2024

Aug 05, 2024

SELL
$154.79 - $180.76 $137,917 - $161,057
-891 Reduced 29.35%
2,145 $367,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $2,397 - $2,731
15 Added 0.5%
3,036 $552,000
Q4 2023

Jan 26, 2024

BUY
$137.6 - $154.97 $825 - $929
6 Added 0.2%
3,021 $468,000
Q3 2023

Oct 27, 2023

SELL
$133.59 - $154.65 $3,206 - $3,711
-24 Reduced 0.79%
3,015 $449,000
Q2 2023

Aug 07, 2023

SELL
$132.51 - $164.9 $6,227 - $7,750
-47 Reduced 1.52%
3,039 $409,000
Q1 2023

May 11, 2023

SELL
$144.61 - $166.54 $62,182 - $71,612
-430 Reduced 12.23%
3,086 $491,000
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $30,981 - $37,154
-224 Reduced 5.99%
3,516 $568,000
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $22,144 - $25,398
-165 Reduced 4.23%
3,740 $502,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $3,715 - $4,723
-27 Reduced 0.69%
3,905 $598,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $16,233 - $20,141
123 Added 3.23%
3,932 $637,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $54,789 - $69,324
-510 Reduced 11.81%
3,809 $516,000
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $71,820 - $81,526
675 Added 18.52%
4,319 $466,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $18,411 - $20,511
175 Added 5.04%
3,644 $410,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $70,587 - $77,707
690 Added 24.83%
3,469 $375,000
Q4 2020

Feb 09, 2021

SELL
$80.49 - $108.67 $198,166 - $267,545
-2,462 Reduced 46.98%
2,779 $298,000
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $4,295 - $5,041
-50 Reduced 0.95%
5,241 $459,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $5,356 - $7,167
73 Added 1.4%
5,291 $489,000
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $51,213 - $77,645
-794 Reduced 13.21%
5,218 $398,000
Q4 2019

Feb 11, 2020

BUY
$72.13 - $90.25 $433,645 - $542,583
6,012 New
6,012 $532,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Indie Asset Partners, LLC Portfolio

Follow Indie Asset Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indie Asset Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indie Asset Partners, LLC with notifications on news.